ArticleFrontiers in oncology2023

Dramatic response and acquired resistance to savolitinib in advanced intrahepatic cholangiocarcinoma with MET amplification: a case report and literature review.

Kexun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.